Your session is about to expire
← Back to Search
Epilepsy Visit Planner for Epilepsy
N/A
Recruiting
Led By Chloe Hill, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after baseline visit
Awards & highlights
Study Summary
This trial assesses whether a tablet-based tool can help improve patient-provider communication & quality of life for those with epilepsy.
Who is the study for?
This trial is for adults with drug-resistant epilepsy who are being treated at the University of Michigan's Epilepsy clinics. Participants must be able to complete study questionnaires in English and not have cognitive impairments that would prevent this.Check my eligibility
What is being tested?
The trial is testing a tablet-based tool called the 'Epilepsy Visit Planner' to see if it improves patient-provider communication and quality of life for epilepsy patients, compared to those who don't use the tool.See study design
What are the potential side effects?
Since this trial involves using a planning tool rather than medication, there are no direct medical side effects. However, participants may experience stress or frustration if they find the technology difficult to use.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months after baseline visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after baseline visit
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Perceived Efficacy in Patient-Physician Interactions Questionnaire (PEPPI), difference in mean score between trial arms
Secondary outcome measures
Acceptability of Intervention Measure, assessed in intervention arm
Feasibility, assessed in intervention arm
Perceived Involvement in Care (PICS), difference in mean score between trial arms
+1 moreTrial Design
3Treatment groups
Experimental Treatment
Group I: Standard care arm - patient participantsExperimental Treatment1 Intervention
This group will be enrolled first.
Group II: Intervention arm (Epilepsy Visit Planner) - provider participantsExperimental Treatment1 Intervention
Epilepsy providers will be recruited from the University of Michigan (approximately 10 providers).
Group III: Intervention arm (Epilepsy Visit Planner) - patient participantsExperimental Treatment2 Interventions
This group will be enrolled after the standard care arm enrollment is completed.
Find a Location
Who is running the clinical trial?
University of MichiganLead Sponsor
1,798 Previous Clinical Trials
6,377,976 Total Patients Enrolled
3 Trials studying Epilepsy
497 Patients Enrolled for Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,341 Previous Clinical Trials
649,427 Total Patients Enrolled
77 Trials studying Epilepsy
24,791 Patients Enrolled for Epilepsy
Chloe Hill, MDPrincipal InvestigatorUniversity of Michigan
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 18 years old.I do not speak English.I cannot complete questionnaires due to cognitive issues.My epilepsy is not clearly drug-resistant.I have epilepsy that doesn't respond to medication.
Research Study Groups:
This trial has the following groups:- Group 1: Standard care arm - patient participants
- Group 2: Intervention arm (Epilepsy Visit Planner) - patient participants
- Group 3: Intervention arm (Epilepsy Visit Planner) - provider participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are recruitment efforts for this research project still ongoing?
"Contrary to expectations, the clinical trial is not accepting patients. Originally posted on July 1st 2023 and subsequently updated 30 days later, there are currently 252 other studies actively recruiting participants."
Answered by AI
Share this study with friends
Copy Link
Messenger